Table 1.

Conditional logistic regression of log-marker levels with active disease vs remission (n = 151). Results expressed as OR for active disease per unit-increase in log-marker level.

MarkerCrude AssociationAdjusted for CRPAdjusted for PR3-ANCAAdjusted for All Markers
OR (95% CI)Std ßOR (95% CI)Std ßOR (95% CI)Std ßOR (95% CI)Std ß
sCD40L4.72 (2.47, 9.03)0.754.26 (2.22, 8.17)0.703.08 (1.60, 5.96)0.543.66 (1.38, 9.72)0.62
CRP1.54 (1.16, 2.04)0.331.47 (1.04, 2.08)0.301.06 (0.59, 1.90)0.05
IL-61.04 (0.63, 1.71)0.010.79 (0.45, 1.40)–0.070.64 (0.34, 1.19)–0.140.92 (0.23, 3.65)–0.02
IL-81.93 (1.33, 2.80)0.331.68 (1.15, 2.47)0.261.89 (1.22, 2.92)0.323.19 (1.23, 8.28)0.59
MCP-10.36 (0.22, 0.57)–0.460.23 (0.13, 0.42)–0.580.45 (0.27, 0.76)–0.350.13 (0.04, 0.51)–0.78
P-selectin6.26 (2.78, 14.10)0.825.26 (2.27, 12.19)0.703.57 (1.52, 8.41)0.572.54 (0.82, 7.84)0.40
VEGF2.13 (1.38, 3.29)0.441.77 (1.13, 2.77)0.332.05 (1.21, 3.46)0.411.28 (0.46, 3.61)0.14
PR3-ANCA9.41 (4.03, 21.99)1.0111.86 (4.40, 31.95)1.105.56 (1.49, 20.74)0.75
  • Std ß: standardized ß estimate; sCD40L: soluble CD40 ligand; CRP: C-reactive protein; IL: interleukin; MCP-1: monocyte chemoattractant protein 1; VEGF: vascular endothelial growth factor; PR3-ANCA: antiproteinase 3 antineutrophil cytoplasmic antibody.